Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-033067
Filing Date
2023-09-19
Accepted
2023-09-19 16:05:26
Documents
1
Period of Report
2023-09-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3935
  Complete submission text file 0001493152-23-033067.txt   5258
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 78 BLANCHARD ROAD BURLINGTON MA 01803
Business Address
Windham-Bannister Susan Richards (Reporting) CIK: 0001713760 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38630 | Film No.: 231263723